Search results for "Retinoid"

showing 10 items of 79 documents

Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands

2002

Constitutive androstane receptor (CAR) and pregnane X receptor (PXR) are members of the nuclear receptor superfamily that regulate target gene transcription in a ligand-dependent manner. CAR and PXR have a rather broad, overlapping set of ligands that range from natural steroids to xenobiotics and also recognize similar DNA binding sites, referred to as response elements (REs), primarily in promoter regions of cytochrome P450 (CYP) genes. In this study, a CAR and PXR RE, composed of a direct repeat of two GGTTCA motifs in a distance of 4 nucleotides (DR4), was identified in the promoter of the human inducible nitric oxide (NO) synthase (iNOS) gene, which is the first nuclear receptor bindin…

Pregnane X receptorCell BiologyRetinoid X receptorBiologydigestive systemBiochemistryCalcitriol receptorCell biologyBiochemistryNuclear receptorDownregulation and upregulationConstitutive androstane receptorBinding siteReceptorMolecular BiologyJournal of Cellular Biochemistry
researchProduct

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

2019

The availability of in vitro tools that are constructed on the basis of a detailed knowledge of key aspects of gastrointestinal (GI) physiology and their impact on formulation performance and subsequent drug release behaviour is fundamental to the success and efficiency of oral drug product development. Over the last six years, the development and optimization of improved, biorelevant in vitro tools has been a cornerstone of the IMI OrBiTo (Oral Biopharmaceutics Tools) project. By bringing together key industry and academic partners, and by linking tool development and optimization to human studies to understand behaviour at the formulation/GI tract interface, the collaboration has enabled …

Process managementUPPER GASTROINTESTINAL-TRACTAdministration OralPharmaceutical Science02 engineering and technologyWATER DIFFUSIVITYModels Biological030226 pharmacology & pharmacyDosage formBiopharmaceutics03 medical and health sciences0302 clinical medicineDISINTEGRATION TESTERHumansPharmacology & PharmacyWEAK BASESIntersectoral CollaborationBiologyTEST DEVICEDosage FormsALBENDAZOLE CONCENTRATIONSScience & TechnologyHuman studiesbusiness.industryBiopharmaceuticsFED STATE CONDITIONSGeneral Medicine021001 nanoscience & nanotechnologyRELEASE TABLETSGastrointestinal TractPharmaceutical PreparationsGastrointestinal AbsorptionGeneral partnershipSOLID DISPERSIONNew product developmentDrug releaseIntersectoral Collaboration0210 nano-technologybusinessLife Sciences & BiomedicineUPPER SMALL-INTESTINEOral retinoidForecastingBiotechnology
researchProduct

Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell gro…

2005

New terphenyl derivatives have been synthesized and tested for their effect on cell survival in serum-free cultures. These compounds protected HL60 cells from death and supported their growth with an activity higher than that of the natural 14-hydroxy-retro-retinol. Terphenyls 26 and 28 also possess antiapoptotic activity on neuronal cells, proving them as possible candidates for the treatment of neurodegenerative and ischemic diseases.

Programmed cell deathNecrosisreceptor-alphamedicine.drug_classmechanismApoptosisHL-60 Cellsnecrosischemistry.chemical_compoundRetinoidsdeathTerphenylDrug DiscoverymedicineHumansRetinoidNeuronsCell growthbiphenyl-4-carboxylic acidarotinoidIn vitroCell biologyCultured cortical-neuronchemistryBiochemistryCell cultureApoptosisretinobenzoic acidMolecular MedicineIndicators and Reagentsmultidrugmedicine.symptomCell Division(14R)-14-hydroxy-414-retro-retinolJournal of medicinal chemistry
researchProduct

Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on mult…

2000

Considering that the stereochemistry of the C9-C10 alkenyl portion of natural 9-cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis or trans configuration of the alkenyl portion. The compounds were evaluated in vitro for their cytotoxic and apoptotic activities. We discovered that the cis-TTNPB 9c possesses apoptotic activity comparable with that of the retinoid 4. Moreover, the amino arotinoid 16c showed potent apoptotic activity in HL60 promyelocytic leukemia cells. Interestingly, 16c proved to be a particularly potent apopt…

Programmed cell deathmedicine.drug_classHL60Clinical BiochemistryPharmaceutical ScienceAntineoplastic AgentsApoptosisHL-60 CellsBiochemistryRetinoidschemistry.chemical_compoundStilbenesDrug DiscoverymedicineHumansCytotoxic T cellRetinoidCytotoxicityMolecular BiologyChemistryOrganic ChemistryDrug Resistance MultipleMultiple drug resistanceBiochemistryApoptosisCell cultureMolecular MedicineK562 CellsBioorganic & Medicinal Chemistry Letters
researchProduct

Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.

2002

Crystal structure and co-regulator interaction studies have led to a general mechanistic view of the initial steps of nuclear receptor (NR) action. Agonist-induced transconformation of the ligand-binding domain (holo-LBD) leads to the formation of co-activator complexes, and destabilizes the co-repressor complexes bound to the ligand-free (apo) LBD. However, the molecular basis of retinoid-X receptor (RXR) 'subordination' in heterodimers, an essential mechanism to avoid signalling pathway promiscuity, has remained elusive. RXR, in contrast to its heterodimer partner, cannot autonomously induce transcription on binding of cognate agonists. Here we show that RXR can bind ligand and recruit co…

Protein ConformationReceptors Retinoic AcidPlasma protein bindingRetinoid X receptorLigandsNuclear Receptor Coactivator 2Structure-Activity RelationshipmedicineNuclear Receptor Co-Repressor 2Binding siteNuclear receptor co-repressor 2PhysicsMultidisciplinaryCell biologyDNA-Binding ProteinsRepressor ProteinsRetinoic acid receptorRetinoid X ReceptorsMechanism of actionBiochemistryNuclear receptorModels Chemicalembryonic structuresNuclear receptor coactivator 2medicine.symptomDimerizationProtein BindingTranscription FactorsNature
researchProduct

Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heter…

1999

In a search for retinoic acid receptor (RAR and RXR)-selective ligands, a series of isoxazole retinoids was synthesized and evaluated in vitro in transcriptional activation and competition binding assays for RARs and RXRs. In addition, these compounds were evaluated for their differentiating, cytotoxic, and apoptotic activities. In general, these derivatives showed scarcely any binding affinity and were not active in the transcriptional assay. However, among these isoxazole derivatives, the cis-isomer 14b was identified as a potent inducer of apoptosis, and its activity was found to be 6.5 and 4 times superior than that of 13-cis- and 9-cis-retinoic acids, respectively. On the other hand, c…

Receptors Retinoic AcidRetinoic acidCarboxylic AcidsApoptosisHL-60 CellsTretinoinRetinoid X receptorchemistry.chemical_compoundRetinoidsStructure-Activity RelationshipDrug DiscoveryStructure–activity relationshipHumansIsoxazoleIsotretinoinAlitretinoinMolecular StructureBiological activityCell DifferentiationStereoisomerismIsoxazolesLigand (biochemistry)In vitroRetinoic acid receptorchemistryBiochemistryMolecular MedicineGranulocytesJournal of medicinal chemistry
researchProduct

Requirement of Retinoic Acid Receptor Isotypes α, β, and γ during the Initial Steps of Neural Differentiation of PCC7 Cells

2005

Retinoic acid (RA) is indispensable for morphogenesis and differentiation of several tissues, including the nervous system. The requirement of the RA receptor (RAR) isotypes alpha, beta, and gamma and the putative role of retinoid X receptor-(RXR) signaling in RA-induced neural differentiation, was analyzed. For this compound-selective retinoids and the murine embryonal carcinoma cell line PCC7, a model system for RA-dependent neural differentiation was used. The present paper shows that proliferating PCC7 cells primarily express RXRalpha and RARalpha, lower levels of RXRbeta, and barely detectable amounts of RARbeta, RARgamma, and RXRgamma. At receptor-selective concentrations, only a RARa…

Receptors Retinoic AcidRetinoic acidReceptors Cytoplasmic and NuclearApoptosisLigandsMicechemistry.chemical_compoundEndocrinologyGenes ReporterNuclear Receptor Subfamily 6 Group A Member 1Protein IsoformsRetinoidReceptorGlutathione TransferaseNeuronsCell DeathReverse Transcriptase Polymerase Chain ReactionCell DifferentiationGeneral MedicineImmunohistochemistryUp-RegulationCell biologyDNA-Binding ProteinsBiochemistrySignal transductionPlasmidsProtein BindingSignal Transductionmedicine.drugTranscriptional ActivationDNA Complementarymedicine.drug_classRecombinant Fusion ProteinsBlotting WesternDown-RegulationTretinoinRetinoid X receptorBiologyTransfectionCell LineTretinoinCell Line TumormedicineAnimalsHumansMolecular BiologyCell ProliferationKineticsRetinoic acid receptorRetinoid X ReceptorschemistryNuclear receptorRNAOctamer Transcription Factor-3Transcription FactorsMolecular Endocrinology
researchProduct

Xanthine dehydrogenase processes retinol to retinoic acid in human mammary epithelial cells

2008

Retinoic acid is considered to be the active metabolite of retinol, able to control differentiation and proliferation of epithelia. Retinoic acid biosynthesis has been widely described with the implication of multiple enzymatic activities. However, our understanding of the cell biological function and regulation of this process is limited. In a recent study we evidenced that milk xanthine oxidase (E.C. 1.17.3.2.) is capable to oxidize all-trans-retinol bound to CRBP (holo-CRBP) to all-trans-retinaldehyde and then to all-trans-retinoic acid. To get further knowledge regarding this process we have evaluated the biosynthetic pathway of retinoic acid in a human mammary epithelial cell line (HME…

Receptors Retinoic AcidXanthine dehydrogenaseCellRetinoic acidOxypurinolTretinoinRetinoic acid receptor betaBiologychemistry.chemical_compoundSettore BIO/10 - BiochimicaDrug DiscoverymedicineHumansMammary Glands HumanVitamin AXanthine oxidaseHMECPharmacologyRetinolEpithelial CellsRetinol-Binding Proteins CellularGeneral MedicineMilk ProteinsNADRetinoic acid receptormedicine.anatomical_structurechemistryBiochemistryXanthine dehydrogenaseRetinol oxidationRetinoic acid receptor alphaRetinoid AcidMetabolic Networks and PathwaysJournal of Enzyme Inhibition and Medicinal Chemistry
researchProduct

Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expres…

2010

Steatosis is the first step in the development of non-alcoholic fatty liver disease (NAFLD). However, the mechanisms involved in its pathogenesis are not fully understood. Many nuclear receptors (NRs) involved in energy homeostasis and biotransformation constitute a network connecting fatty acids, cholesterol and xenobiotic metabolisms; therefore, multiple NRs and their ligands may play a prominent role in liver fat metabolism and accumulation. In this study we have attempted to gain insight into the relevance of the NR superfamily in NAFLD by investigating the steatogenic potential of 76 different NR ligands in fatty acid overloaded human hepatocytes and hepatoma cells. Moreover, we have d…

Selective Estrogen Receptor ModulatorsIndolesPeroxisome proliferator-activated receptorReceptors Cytoplasmic and NuclearBiologyRetinoid X receptorPhloroglucinolToxicologyLigandsCalcitriol receptorBridged Bicyclo CompoundsPregnenedionesmedicineHumansLiver X receptorVitamin ACells CulturedCalcifediolchemistry.chemical_classificationPregnane X receptorAndrostenolsTerpenesFatty liverFatty acidGeneral MedicineHep G2 Cellsmedicine.diseaseFarnesolFatty LiverPPAR gammaTamoxifenCholesterolNuclear receptorchemistryBiochemistryHepatocytesChemico-biological interactions
researchProduct

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academ…

2016

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed specifically for patients with this disease entity, and topical and systemic drugs are mostly used 'off-label'. The aim of the present guideline was to achieve a broad consensus on treatment strategies for patients with CLE by a European subcommittee, guided by the European Dermatology Forum (EDF) and supported by the European Academy of Dermatology and Venereology (EADV). In total, 16 European participants were included in this project and agreed on all recommendations. Topical corticosteroids remain the mainstay of trea…

Systemic diseasemedicine.medical_specialtyVenereologyConsensusCalcineurin InhibitorsDermatologyDapsone030207 dermatology & venereal diseases03 medical and health sciencesAntimalarialsRetinoids0302 clinical medicineAdrenal Cortex HormonesmedicineLupus Erythematosus CutaneousHumans610 Medicine & healthlupus erythematous cuteneous guidelines treatmentLenalidomideLenalidomide030203 arthritis & rheumatologyBiological ProductsLupus erythematosusbusiness.industryfungiGuidelineMycophenolic Acidmedicine.diseaseDermatologyThalidomideClinical trialThalidomideInfectious DiseasesMethotrexatePractice Guidelines as TopicbusinessDapsoneImmunosuppressive Agentsmedicine.drug
researchProduct